Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. [electronic resource]
Producer: 20180129Description: 11919-11924 p. digitalISSN:- 1091-6490
- Antineoplastic Agents, Immunological -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers
- CD8-Positive T-Lymphocytes -- immunology
- Clinical Trials, Phase II as Topic
- Clonal Evolution -- immunology
- Disease Susceptibility
- Drug-Related Side Effects and Adverse Reactions -- diagnosis
- Humans
- Ipilimumab -- adverse effects
- Lymphocyte Count
- Male
- Middle Aged
- Prostatic Neoplasms -- complications
- Severity of Illness Index
- T-Lymphocyte Subsets -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.